[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100419147":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":43,"locations":49,"responsibleParty":108,"collaborators":111,"id":113,"slug":114,"hasResults":115,"nctId":116,"briefTitle":117,"officialTitle":118,"acronym":26,"eligibilityCriteria":119,"healthyVolunteers":115,"sex":120,"minAge":121,"maxAge":26,"enrollmentInfo":122,"targetDuration":26,"studyType":125,"phases":126,"briefSummary":128,"conditions":129,"keywords":131,"overallStatus":51,"whyStopped":26,"lastUpdateSubmitDate":133,"lastUpdatePostDateStruct":134,"startDateStruct":137,"completionDateStruct":139,"leadSponsor":141,"locationsCount":142},{"fullName":5,"class":6},"Oulu University Hospital","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"First-visit foam sclerotherapy","EXPERIMENTAL","Patients in the first-visit foam sclerotherapy group undergo first-visit foam sclerotherapy (including sub-ulcer foam sclerotherapy), and truncal vein endothermal ablation is scheduled when the anatomy is suitable. Compression therapy is initiated immediately.",[13,14],"Procedure: Endothermal Ablation","Procedure: Foam Sclerotherapy",{"label":16,"type":17,"description":18,"interventionNames":19},"Scheduled treatment","ACTIVE_COMPARATOR","Patients in the scheduled treatment group receive scheduled endovenous ablation, including foam sclerotherapy and\u002For endothermal ablation, depending on reflux anatomy. This group represents the current standard of care. Compression therapy is initiated immediately.",[13,14],[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Endothermal Ablation","Endothermal ablation is performed to suitable insufficient truncal veins (Great-, Anterior Accessory- and\u002For Small Saphenous Vein)",[9,16],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Foam Sclerotherapy","Foam sclerotherapy is performed to insufficient veins distal to the truncal superficial veins.",[9,16],[32,35,38,41],{"name":33,"affiliation":5,"role":34},"Toni Pihlaja, MD","PRINCIPAL_INVESTIGATOR",{"name":36,"affiliation":37,"role":34},"Karoliina Halmesmaki, Docent","Helsinki University Central Hospital",{"name":39,"affiliation":37,"role":40},"Maarit Venermo, Professor","STUDY_CHAIR",{"name":42,"affiliation":5,"role":40},"Matti Pokela, Docent",[44],{"name":42,"role":45,"phone":46,"phoneExt":47,"email":48},"CONTACT","083152011","+315","matti.pokela@ppshp.fi",[50,64,75,84,96],{"facility":37,"status":51,"city":52,"state":26,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"RECRUITING","Helsinki","Finland","FI",{"type":56,"coordinates":57},"Point",[58,59],24.93545,60.16952,{"lat":59,"lon":58},[62],{"name":36,"role":45,"phone":26,"phoneExt":26,"email":63},"karoliina.halmesmaki@hus.fi",{"facility":65,"status":51,"city":66,"state":26,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"Keski-Suomen keskussairaala","Jyväskylä",{"type":56,"coordinates":68},[69,70],25.72088,62.24147,{"lat":70,"lon":69},[73],{"name":74,"role":45,"phone":26,"phoneExt":26,"email":26},"Tiia Kukkonen",{"facility":5,"status":51,"city":76,"state":26,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Oulu",{"type":56,"coordinates":78},[79,80],25.46816,65.01236,{"lat":80,"lon":79},[83],{"name":42,"role":45,"phone":26,"phoneExt":26,"email":48},{"facility":85,"status":51,"city":86,"state":26,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":87,"geoPoint":91,"contacts":92},"Turku University Hospital","Turku",{"type":56,"coordinates":88},[89,90],22.26869,60.45148,{"lat":90,"lon":89},[93],{"name":94,"role":45,"phone":26,"phoneExt":26,"email":95},"Harri Hakovirta, Professor","harri.hakovirta@tyks.fi",{"facility":97,"status":51,"city":98,"state":26,"zip":26,"country":53,"countryCode":54,"cosmosGeoPoint":99,"geoPoint":103,"contacts":104},"Vaasa Central Hospital","Vaasa",{"type":56,"coordinates":100},[101,102],21.61577,63.096,{"lat":102,"lon":101},[105],{"name":106,"role":45,"phone":26,"phoneExt":26,"email":107},"Vesa Rajala, MD","vesa.rajala@vshp.fi",{"type":34,"investigatorFullName":109,"investigatorTitle":110,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Toni Pihlaja","Principal Investigator",[112],{"name":37,"class":6},"100419147","finnish-venous-ulcer-study-finnulcer-study-100419147",false,"NCT04737941","Finnish Venous Ulcer Study (FINNULCER Study)","Finnish Venous Ulcer Study","Inclusion Criteria:\n\n* Patient informed consent\n* Venous ulcer, aged from one month to one year\n* Duplex ultrasonography verified (vein reflux greater than \\>0.5 second) superficial venous insufficiency\n* Sufficient arterial circulation (at least on criterion met: Palpable distal pulses \u002F ankle-brachial index \\> 0,8 \u002F Toe pressure \\>60mmhg)\n\nExclusion Criteria:\n\n* Leg ulcers other than venous etiology\n* Ulcers requiring operation theater revision\n* Patent foramen ovale\n* Several times recurrent (over 3 recurrences) venous ulcer\n* Body Mass Index over 40\n* Pregnancy","ALL","18 Years",{"count":123,"type":124},248,"ESTIMATED","INTERVENTIONAL",[127],"NA","This multicenter randomized controlled trial evaluates the effect of first-visit foam sclerotherapy (including sub-ulcer foam sclerotherapy) in patients with venous leg ulcer.",[130],"Venous Leg Ulcer",[130,28,23,132],"Sub-ulcer Foam Sclerotherapy","2025-01-13",{"date":135,"type":136},"2025-01-15","ACTUAL",{"date":138,"type":136},"2021-02-26",{"date":140,"type":124},"2026-03-01",{"name":5,"class":6},5]